Unlocking the potential of hyper-collaboration in Life Sciences: Accelerate breakthroughs together
Great collaboration is the foundation of any successful business. But for Life Sciences, especially post-COVID, where people's health is on the line, collaboration is critical
CLOSE
What you will learn
- Learn what hyper-collaboration is and its importance in Life Sciences today.
- Discover how AstraZeneca fostered a culture of collaboration with “Science meets digital.”
- Explore tools available today to make hyper-collaboration a reality in your organization.
Hyper-collaboration driving success in Life Sciences
This webinar dives deep into the power of hyper-collaboration in the life sciences industry. Explore how leveraging diverse expertise across teams drives innovation and improves regulatory compliance. Learn from AstraZeneca’s journey in fostering digital collaboration, reducing time to market, and improving quality control.
Meet our speaker

Sophie Bailes
R&D IT Capability Lead CMC, AstraZenecaSophie joined AstraZeneca in 2005, holding key roles in chemical development and digital transformation projects. As an advocate for digital adoption, she integrated key technologies for data transfer and analysis, driving efficiency and accuracy in complex development projects.
Frequently asked questions
